{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T05:50:51Z","timestamp":1773813051249,"version":"3.50.1"},"reference-count":24,"publisher":"Springer Science and Business Media LLC","issue":"1","funder":[{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["IG 17387"],"award-info":[{"award-number":["IG 17387"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005010","name":"Associazione Italiana per la Ricerca sul Cancro","doi-asserted-by":"publisher","award":["Livia Perotti"],"award-info":[{"award-number":["Livia Perotti"]}],"id":[{"id":"10.13039\/501100005010","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Mol Cancer"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1186\/s12943-017-0614-y","type":"journal-article","created":{"date-parts":[[2017,2,27]],"date-time":"2017-02-27T05:14:23Z","timestamp":1488172463000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":13,"title":["Mitochondrial DNA sequencing demonstrates clonality of peritoneal implants of borderline ovarian tumors"],"prefix":"10.1186","volume":"16","author":[{"given":"Giulia","family":"Girolimetti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierandrea","family":"De Iaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martina","family":"Procaccini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Panzacchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivana","family":"Kurelac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laura Benedetta","family":"Amato","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Dondi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giacomo","family":"Caprara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claudio","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Donatella","family":"Santini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Maria","family":"Porcelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna Myriam","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1229-9006","authenticated-orcid":false,"given":"Giuseppe","family":"Gasparre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2017,2,27]]},"reference":[{"key":"614_CR1","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.ejogrb.2009.04.031","volume":"145","author":"MS Lenhard","year":"2009","unstructured":"Lenhard MS, Mitterer S, Kumper C, Stieber P, Mayr D, Ditsch N, et al. Long-term follow-up after ovarian borderline tumor: relapse and survival in a large patient cohort. Eur J Obstet Gynecol Reprod Biol. 2009;145:189\u201394.","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"614_CR2","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1097\/00003081-200609000-00011","volume":"49","author":"MB Jones","year":"2006","unstructured":"Jones MB. Borderline ovarian tumors: current concepts for prognostic factors and clinical management. Clin Obstet Gynecol. 2006;49:517\u201325.","journal-title":"Clin Obstet Gynecol"},{"key":"614_CR3","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1053\/clon.1999.9017","volume":"11","author":"S Manek","year":"1999","unstructured":"Manek S, Wells M. Pathology of borderline ovarian tumours. Clin Oncol R Coll Radiol G B. 1999;11:73\u20137.","journal-title":"Clin Oncol R Coll Radiol G B"},{"key":"614_CR4","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/j.ygyno.2012.02.017","volume":"125","author":"J Menczer","year":"2012","unstructured":"Menczer J, Chetrit A, Sadetzki S. The effect of hysterectomy on survival of patients with borderline ovarian tumors. Gynecol Oncol. 2012;125:372\u20135.","journal-title":"Gynecol Oncol"},{"key":"614_CR5","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2214\/AJR.09.3936","volume":"194","author":"N Lalwani","year":"2010","unstructured":"Lalwani N, Shanbhogue AKP, Vikram R, Nagar A, Jagirdar J, Prasad SR. Current update on borderline ovarian neoplasms. AJR Am J Roentgenol. 2010;194:330\u20136.","journal-title":"AJR Am J Roentgenol"},{"key":"614_CR6","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1053\/hp.2000.8048","volume":"31","author":"JD Seidman","year":"2000","unstructured":"Seidman JD, Kurman RJ. Ovarian serous borderline tumors: a critical review of the literature with emphasis on prognostic indicators. Hum Pathol. 2000;31:539\u201357.","journal-title":"Hum Pathol"},{"key":"614_CR7","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","volume":"30","author":"EG Silva","year":"2006","unstructured":"Silva EG, Gershenson DM, Malpica A, Deavers M. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent. Am J Surg Pathol. 2006;30:1367\u201371.","journal-title":"Am J Surg Pathol"},{"key":"614_CR8","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1002\/(SICI)1097-0142(19981115)83:10<2157::AID-CNCR14>3.0.CO;2-D","volume":"83","author":"DM Gershenson","year":"1998","unstructured":"Gershenson DM, Silva EG, Tortolero-Luna G, Levenback C, Morris M, Tornos C. Serous borderline tumors of the ovary with noninvasive peritoneal implants. Cancer. 1998;83:2157\u201363.","journal-title":"Cancer"},{"key":"614_CR9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ygyno.2006.10.031","volume":"104","author":"NR Abu-Rustum","year":"2007","unstructured":"Abu-Rustum NR, Sonoda Y. Transperitoneal laparoscopic staging with aortic and pelvic lymph node dissection for gynecologic malignancies. Gynecol Oncol. 2007;104:5\u20138.","journal-title":"Gynecol Oncol"},{"key":"614_CR10","first-page":"2328","volume":"58","author":"KH Lu","year":"1998","unstructured":"Lu KH, Bell DA, Welch WR, Berkowitz RS, Mok SC. Evidence for the multifocal origin of bilateral and advanced human serous borderline ovarian tumors. Cancer Res. 1998;58:2328\u201330.","journal-title":"Cancer Res"},{"key":"614_CR11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/path.2074","volume":"210","author":"NL Sieben","year":"2006","unstructured":"Sieben NL, Roemen GMJM, Oosting J, Fleuren GJ, van Engeland M, Prat J. Clonal analysis favours a monoclonal origin for serous borderline tumours with peritoneal implants. J Pathol. 2006;210:405\u201311.","journal-title":"J Pathol"},{"key":"614_CR12","first-page":"1412","volume":"27","author":"F Guerra","year":"2014","unstructured":"Guerra F, Girolimetti G, Perrone AM, Procaccini M, Kurelac I, Ceccarelli C, et al. Mitochondrial DNA genotyping efficiently reveals clonality of synchronous endometrial and ovarian cancers. Mod Pathol Off J U S Can Acad Pathol Inc. 2014;27:1412\u201320.","journal-title":"Mod Pathol Off J U S Can Acad Pathol Inc"},{"key":"614_CR13","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.ygyno.2011.04.036","volume":"122","author":"F Guerra","year":"2011","unstructured":"Guerra F, Kurelac I, Magini P, Cormio A, Santini D, Ceccarelli C, et al. Mitochondrial DNA genotyping reveals synchronous nature of simultaneously detected endometrial and ovarian cancers. Gynecol Oncol. 2011;122:457\u20138.","journal-title":"Gynecol Oncol"},{"key":"614_CR14","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1093\/hmg\/ddr146","volume":"20","author":"F Guerra","year":"2011","unstructured":"Guerra F, Kurelac I, Cormio A, Zuntini R, Amato LB, Ceccarelli C, et al. Placing mitochondrial DNA mutations within the progression model of type I endometrial carcinoma. Hum Mol Genet. 2011;20:2394\u2013405.","journal-title":"Hum Mol Genet"},{"key":"614_CR15","doi-asserted-by":"crossref","first-page":"3115","DOI":"10.1093\/bioinformatics\/btu483","volume":"30","author":"C Calabrese","year":"2014","unstructured":"Calabrese C, Simone D, Diroma MA, Santorsola M, Gutta C, Gasparre G, et al. MToolBox: a highly automated pipeline for heteroplasmy annotation and prioritization analysis of human mitochondrial variants in high-throughput sequencing. Bioinforma Oxf Engl. 2014;30:3115\u20137.","journal-title":"Bioinforma Oxf Engl"},{"key":"614_CR16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00439-015-1615-9","volume":"135","author":"M Santorsola","year":"2016","unstructured":"Santorsola M, Calabrese C, Girolimetti G, Diroma MA, Gasparre G, Attimonelli M. A multi-parametric workflow for the prioritization of mitochondrial DNA variants of clinical interest. Hum Genet. 2016;135:121\u201336.","journal-title":"Hum Genet"},{"key":"614_CR17","doi-asserted-by":"crossref","first-page":"D1150","DOI":"10.1093\/nar\/gkr1086","volume":"40","author":"F Rubino","year":"2012","unstructured":"Rubino F, Piredda R, Calabrese FM, Simone D, Lang M, Calabrese C, et al. HmtDB, a genomic resource for mitochondrion-based human variability studies. Nucleic Acids Res. 2012;40:D1150\u20131159.","journal-title":"Nucleic Acids Res"},{"key":"614_CR18","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.biotechadv.2011.06.001","volume":"30","author":"I Kurelac","year":"2012","unstructured":"Kurelac I, Lang M, Zuntini R, Calabrese C, Simone D, Vicario S, et al. Searching for a needle in the haystack: comparing six methods to evaluate heteroplasmy in difficult sequence context. Biotechnol Adv. 2012;30:363\u201371.","journal-title":"Biotechnol Adv"},{"key":"614_CR19","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-7091-1824-5","volume-title":"Tumor Cell Metabolism Pathways, Regulation and Biology","author":"S Mazurek","year":"2015","unstructured":"Mazurek S, Shoshan MC. Tumor Cell Metabolism Pathways, Regulation and Biology. Wien: u.a.: Springer; 2015."},{"key":"614_CR20","doi-asserted-by":"crossref","first-page":"14087","DOI":"10.1073\/pnas.1211502109","volume":"109","author":"TC Larman","year":"2012","unstructured":"Larman TC, DePalma SR, Hadjipanayis AG, Protopopov A, Zhang J, Gabriel SB, et al. Spectrum of somatic mitochondrial mutations in five cancers. Proc Natl Acad Sci U S A. 2012;109:14087\u201391.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"614_CR21","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1093\/hmg\/ddp069","volume":"18","author":"JS Park","year":"2009","unstructured":"Park JS, Sharma LK, Li H, Xiang R, Holstein D, Wu J, et al. A heteroplasmic, not homoplasmic, mitochondrial DNA mutation promotes tumorigenesis via alteration in reactive oxygen species generation and apoptosis. Hum Mol Genet. 2009;18:1578\u201389.","journal-title":"Hum Mol Genet"},{"key":"614_CR22","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.1038\/bjc.2012.505","volume":"107","author":"S Masuda","year":"2012","unstructured":"Masuda S, Kadowaki T, Kumaki N, Tang X, Tokuda Y, Yoshimura S, et al. Analysis of gene alterations of mitochondrial DNA D-loop regions to determine breast cancer clonality. Br J Cancer. 2012;107:2016\u201323.","journal-title":"Br J Cancer"},{"key":"614_CR23","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00428-015-1817-5","volume":"467","author":"WRR Geurts-Giele","year":"2015","unstructured":"Geurts-Giele WRR, Gathier GHGK, Atmodimedjo PN, Dubbink HJ, Dinjens WNM. Mitochondrial D310 mutation as clonal marker for solid tumors. Virchows Arch Int J Pathol. 2015;467:595\u2013602.","journal-title":"Virchows Arch Int J Pathol"},{"key":"614_CR24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1477-3163-6-1","volume":"6","author":"FO Aikhionbare","year":"2007","unstructured":"Aikhionbare FO, Mehrabi S, Kumaresan K, Zavareh M, Olatinwo M, Odunsi K, et al. Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J Carcinog. 2007;6:1.","journal-title":"J Carcinog"}],"container-title":["Molecular Cancer"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s12943-017-0614-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,10,3]],"date-time":"2020-10-03T03:56:47Z","timestamp":1601697407000},"score":1,"resource":{"primary":{"URL":"http:\/\/molecular-cancer.biomedcentral.com\/articles\/10.1186\/s12943-017-0614-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2017,2,27]]},"references-count":24,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["614"],"URL":"https:\/\/doi.org\/10.1186\/s12943-017-0614-y","relation":{},"ISSN":["1476-4598"],"issn-type":[{"value":"1476-4598","type":"electronic"}],"subject":[],"published":{"date-parts":[[2017,2,27]]},"article-number":"47"}}